Legal Representation
Attorney
Brian J. Focarino
USPTO Deadlines
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 11, 2022 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Jul 11, 2022 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Dec 20, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 20, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 20, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 17, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 27, 2021 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jul 29, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 26, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for the treatment of diseases in the field of neuroscience, namely, depressive symptoms in a variety of psychiatric conditions, namely, depression, bipolar disorder, anxiety disorders, namely, obsessive-compulsive disorder and PTSD
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Scientific and medical research in the field of neuroscience, namely, depressive symptoms in a variety of psychiatric conditions, namely, depression, bipolar disorder, anxiety disorders, namely, obsessive-compulsive disorder, PTSD, and concerning antidepressants; consultation related thereto; providing information about medical research
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Providing medical information and news in the field of neuroscience, namely, depressive symptoms in a variety of psychiatric conditions, namely, depression, bipolar disorder, anxiety disorders, namely, obsessive-compulsive disorder, PTSD, and concerning antidepressants
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
042
044